Literature DB >> 28638001

Comparison between Glioblastoma and Primary Central Nervous System Lymphoma Using MR Image-based Texture Analysis.

Akira Kunimatsu1,2, Natsuko Kunimatsu3, Kouhei Kamiya4, Takeyuki Watadani4, Harushi Mori1, Osamu Abe1.   

Abstract

PURPOSE: To elucidate differences between glioblastoma (GBM) and primary central nervous system lymphoma (PCNSL) with MR image-based texture features.
METHODS: This was an Institutional Review Board (IRB)-approved retrospective study. Consecutive, pathologically proven, initially treated 44 patients with GBM and 16 patients with PCNSL were enrolled. We calculated a total of 67 image texture features on the largest contrast-enhancing lesion in each patient on post-contrast T1-weighted images. Texture analyses included first-order features (histogram) and second-order features calculated with gray level co-occurrence matrix, gray level run length matrix (GLRLM), gray level size zone matrix, and multiple gray level size zone matrix. All texture features were measured by two neuroradiologists independently and the intraclass correlation coefficients were calculated. Reproducible features with the intraclass correlation coefficients of greater than 0.7 were used for hierarchical clustering between the cases and the features along with unpaired t statistics-based comparisons under the control of false discovery rate (FDR) < 0.05. Principal component analysis (PCA) was performed to find the predominant features in evaluating the differences between GBM and PCNSL.
RESULTS: Twenty-one out of the 67 features satisfied the acceptable intraclass correlation coefficient and the FDR constraints. PCA suggested first-order entropy, median, GLRLM-based run length non-uniformity, and run percentage as the distinguished features. Compared with PCNSL, run percentage and median were significantly lower, and entropy and run length non-uniformity were significantly higher in GBM.
CONCLUSIONS: Among MR image-based textures, first-order entropy, median, GLRLM-based run length non-uniformity, and run percentage are considered to enhance differences between GBM and PCNSL.

Entities:  

Keywords:  glioblastoma; magnetic resonance imaging; primary central nervous system lymphoma; texture analysis

Mesh:

Year:  2017        PMID: 28638001      PMCID: PMC5760233          DOI: 10.2463/mrms.mp.2017-0044

Source DB:  PubMed          Journal:  Magn Reson Med Sci        ISSN: 1347-3182            Impact factor:   2.471


Introduction

Glioblastoma or glioblastoma multiforme (GBM) is a high grade glioma with predominantly astrocytic differentiation that corresponds to the grade IV by the classification of the central nervous system (CNS) tumors from the World Health Organization (WHO).[1] GBM accounts for approximately 15% of all intracranial neoplasms and is the most frequent malignant brain tumor in adults. GBM preferentially affects adults with a peak incidence between 45 and 75 years with a slight male predominance. Primary CNS lymphoma (PCNSL) is a nervous-system-seeking, extranodal, non-Hodgkin’s lymphoma.[2] It occurs in the brain, meninges, spinal cord, nerve roots, or eyes, and typically remains confined to the CNS. PCNSL accounts for 3.1% of all primary brain neoplasms with a slight male predominance as well. PCNSL most commonly affects adults with the median age of 53 to 57 years at diagnosis of PCNSL in immunocompetent patients.[3] Despite an approximately 5-fold higher incidence of GBM over PCNSL, GBM and PCNSL share common features in age at presentation and gender predominance; thus, they reasonably include each other in the differential diagnosis. However, treatment strategies substantially differ between GBM and PCNSL. For GBM, maximal tumor resection followed by radiation therapy and chemotherapy with temozolomide is the current treatment of choice,[4] whereas for PCNSL, stereotactic intracranial biopsy followed by methotrexate-based chemotherapy is usually chosen.[2] Therefore, preoperative differentiation of GBM and PCNSL is of high clinical relevance.[5] Post-contrast brain MR imaging findings are well-established on GBM and PCNSL: GBM typically exhibits thick, irregular, ring-like or heterogeneous enhancement with central hypo-intense necrosis, whereas PCNSL typically exhibits solid homogeneous enhancement in immunocompetent patients.[6,7] Findings on post-contrast MR images largely contribute to making the preoperative diagnosis. However, this pattern is not reliable in some clinical scenarios because atypical, solid enhancing GBM without visible necrosis may mimic PCNSL, and atypical PCNSL with visible necrosis may mimic GBM in tumor appearance.[5] Therefore, the image-based visual analysis of GBM and PCNSL remains to be improved. Texture analysis describes a variety of image-analysis techniques that quantify the variation in surface intensity or patterns, including some that are imperceptible to the human visual system.[8] Texture analysis can be applied to a variety of digital images, and thus, is recently attracting increasing interest in the context of future utilization of artificial intelligence in the field of medical imaging. In oncological neuroimaging, recent MR image-based texture analysis studies reported differentiation between radionecrosis from brain tumor recurrence,[9] patient survival in GBM,[10] grading of cerebral gliomas,[11] differentiation of brain metastases from different pathologies,[12] and differentiation of the posterior fossa tumors.[13] To our knowledge, however, there have been no reports on the analysis of GBM and PCNSL with texture features derived from post-contrast MR images. The purpose of this study was to elucidate the differences between GBM and PCNSL using post-contrast MR image-based texture features.

Materials and Methods

Subjects

We first performed a database search on our radiology report up to August 2015. The search criteria were 1) initial case of pathologically proven GBM or CNS lymphoma, and 2) contrast-enhanced brain MRI performed on a 3-T unit with our brain tumor imaging protocol before surgical operation or biopsy. Initially, 52 consecutive patients with GBM and 18 consecutive patients with CNS lymphoma, from December 2006 through August 2015, fulfilled these inclusion criteria. Pathological diagnosis was based on the WHO 2007 classification, as the WHO revised the classification in 2016. However, 8 of the 52 patients with GBM were excluded due to presence of motion artifacts (n = 5), non-enhancing tumor (n = 1), history of previous surgery for diffuse astrocytoma (n = 1), and protocol violation (n = 1). All of the CNS lymphomas were diffuse large B-cell subtype that developed in immunocompetent patients. Two patients with concurrent CNS involvement of systemic lymphoma were excluded. Neither AIDS-related nor Epstein-Barr virus-related lymphoma was included in our case cohort.[14] Finally, 44 GBM patients (30 men and 14 women; mean age: 61.5 years, range 26 to 81) and 16 PCNSL patients (13 men and 3 women, mean age: 60.6 years, range 42 to 75) were included in this study (Fig. 1).
Fig. 1.

Flow chart of subject enrollment. GBM, glioblastoma; CNS, central nervous system; PCNSL, primary central nervous system lymphoma.

MR imaging

Using the picture archiving and communication system of our hospital, post-contrast trans-axial spin-echo T1-weighted images were retrieved from MR images obtained with our 3-T brain tumor protocol. All MR images were obtained on a 3-T system (Signa HDx, system versions of 14 and of 15 after system software upgrade, GE Healthcare UK Ltd, Little Chalfont, England) and imaging parameters were as follows: TR/TE (ms) = 400/minimum, FOV = 21.0 cm, matrix = 256 × 256, slice thickness = 5 mm. All patients received one of the following gadolinium-based contrast agents at the rate of 0.1 mmol/kg body weight: gadopentetate dimeglumine (Magnevist, Bayer Yakuhin, Ltd., Osaka, Japan), gadodiamide hydrate (Omniscan, Daiichi Sankyo Co., Ltd., Tokyo, Japan), gadoteridol (ProHance, Eisai Co., Ltd., Tokyo, Japan), or gadoterate meglumine (Magnescope, Fuji Pharma Co., Ltd., Tokyo, Japan).

Image analysis

First, a post-contrast T1-weighted image that harbored the largest contrast-enhancing lesion was selected for each case. The images in the Digital Imaging and COmmunication in Medicine (DICOM) format were converted to 8-bit images using image processing software (ImageJ 1.48, National Institute of Health, Bethesda, USA, http://imagej.nih.gov/ij) along with intensity standardization. Then, using numerical analysis software (MATLAB 2014a, The Mathworks, Tokyo, Japan), the anonymized image was shown and a rectangular ROI was carefully placed within the enhancing lesion as large as possible independently by two neuroradiologists with 20 and 21 years of experience, respectively (Fig. 2). All voxel values within the rectangular ROI were recorded.
Fig. 2.

Pretreatment post-contrast T1-weighted image of a 68-year-old man subsequently diagnosed with glioblastoma. Post-contrast T1-weighted image shows a heterogeneously enhanced tumor in the left medial temporal lobe. A rectangular region of interest is placed on the tumor.

Image texture feature extraction

We used software for statistical computing and graphics (R 3.1.2, The R Foundation for Statistical Computing, Vienna, Austria, https://cran.r-project.org/) for texture feature calculation. We obtained first-order texture features and second-order features calculated with gray level co-occurrence matrix (GLCM), gray level run length matrix (GLRLM), gray level size zone matrix (GLSZM), and multiple gray level size zone matrix (mGLSZM),[15] provided in the radiomics package (Joel Carlson [2016]. radiomics: Radiomic Image Processing Toolbox, R package version 0.1.2.). A displacement vector with the distance of one was set at typical angle of 0, 45, 90, and 135 degrees, and the corresponding values were averaged such that GLCM and GLRLM became rotationally invariant. A total set of 67 texture features after standardization (z-scoring) were extracted for each case (Table 1).
Table 1.

MR imaging-based texture features included in this study

Feature noTexture feature
First-order texture
1Energy
2Entropy
3Kurtosis
4Mean deviation
5Skewness
6Uniformity
7Mean
8Median
9Max
10Min
11Variance
12Root mean square
13Standard deviation
Gray level co-occurrence matrix features
14Mean
15Variance
16Autocorrelation
17Cluster prominence
18Cluster shade
19Cluster tendency
20Contrast
21Correlation
22Difference entropy
23Dissimilarity
24Energy
25Entropy
26Homogeneity
27Homogeneity 2
28Inverse difference moment (normalized)
29Inverse difference (normalized)
30Inverse variance
31Maximum probability
32Sum average
33Sum entropy
34Sum variance
Gray level run length matrix features
35Gray level non-uniformity
36High-gray level run emphasis
37Long run emphasis
38Long run high-gray level emphasis
39Long run low-gray level emphasis
40Low-gray level run emphasis
41Run length non-uniformity
42Run percentage
43Short run emphasis
44Short run high-gray level emphasis
45Short run low-gray level emphasis
Gray level size zone matrix features
46Small area emphasis
47Large area emphasis
48Intensity variability
49Size zone variability
50Zone percentage
51Low-intensity emphasis
52High-intensity emphasis
53Low-intensity small area emphasis
54High-intensity small area emphasis
55Low-intensity large area emphasis
56High-intensity large area emphasis
Multiple gray level size zone matrix features
57Multiple gray level small area emphasis
58Multiple gray level large area emphasis
59Multiple gray level intensity variability
60Multiple gray level size zone variability
61Multiple gray level zone percentage
62Multiple gray level low-intensity emphasis
63Multiple gray level high-intensity emphasis
64Multiple gray level low-intensity small area emphasis
65Multiple gray level high-intensity small area emphasis
66Multiple gray level low-intensity large area emphasis
67Multiple gray level high-intensity large area emphasis

Statistical analyses

After the Kolmogrov-Smirnov test for normality, the intraclass correlation coefficient (ICC) was measured with the two-way random model to evaluate the interobserver reproducibility.[16] An intraclass correlation coefficient of greater than 0.7 was considered reliable according to the literature,[17,18] and the features with the coefficients above 0.7 were included in the following analyses after averaging. Hierarchical clustering was performed using Ward’s method. We explored which texture features significantly differed between GBM and PCNSL with unpaired t statistics-based multiple comparisons, provided by the OCplus package under the control of false discovery rate (FDR) < 0.05 (Yudi Pawitan and Alexander Ploner [2016]. OCplus: Operating characteristics plus sample size and local fdr for microarray experiments. R package version 1.48.2.). Finally, principal component analysis (PCA) was performed to find the predominant features from among highly correlated features with one another. All statistical analyses were performed with MATLAB and R packages.

Results

Results of ROI measurement and reproducibility

The median size of the ROIs placed by the radiologists was 413.8 mm2 with the interquartile range of 204.9–658.6 mm2. The box-whisker plot (Fig. 3) shows the distribution of the intraclass correlation coefficients. The median of the intraclass correlation coefficients was 0.74. Twenty-eight texture features demonstrated the intraclass correlation coefficients above 0.7 (Table 2): 11 first-order features, 7 GLCM features, 3 GLRLM features, 3 GLSZM features, and 4 mGLSZM features. In particular, six first-order features showed an intraclass correlation coefficient larger than 0.9. This may indicate that first-order features are more robust and reproducible due to simplicity of calculation, compared with second-order matrix features.
Fig. 3.

The box-whisker plot of the intraclass correlation coefficients. The box indicates interquartile range, and the whiskers indicate range, excluding outliers. The circle represents an outlier, defined as having a distance greater than 1.5-times the interquartile range below the first quartile or above the third quartile. The horizontal line in the box represents the median.

Table 2.

Interobserver reproducibility and comparison results between feature expressions of GBM and PCNSL

Feature noTexture featureReproducibilityComparison[§]

ICC (95% CI)t-value
First-order texture features
2Entropy0.88 (0.80–0.92)3.41*
3Kurtosis0.74 (0.60–0.83)−2.10*
4Mean deviation0.94 (0.91–0.97)3.05*
5Skewness0.73 (0.59–0.83)0.69*
6Uniformity0.86 (0.78–0.91)−2.52*
7Mean0.95 (0.92–0.97)−2.05*
8Median0.94 (0.90–0.96)−1.97
9Max0.95 (0.91–0.97)1.33
10Min0.71 (0.56–0.82)−3.59*
12Root mean square0.95 (0.91–0.97)−1.75
13Standard deviation0.93 (0.88–0.96)3.16*
Gray level co-occurrence matrix features
16Autocorrelation0.71 (0.55–0.82)−2.81*
22Difference entropy0.73 (0.59–0.83)−0.97
25Entropy0.73 (0.58–0.83)0.77*
26Homogeneity0.73 (0.58–0.83)1.71*
27Homogeneity 20.72 (0.57–0.82)1.68*
32Sum average0.74 (0.61–0.84)−2.95*
34Sum variance0.72 (0.57–0.82)−2.87*
Gray level run length matrix features
41Run length non-uniformity0.95 (0.91–0.97)2.54*
42Run percentage0.77 (0.65–0.86)−2.11*
43Short run emphasis0.74 (0.60–0.84)−1.66*
Gray level size zone matrix features
46Small area emphasis0.76 (0.63–0.85)−0.82
48Intensity variability0.95 (0.92–0.97)2.12*
50Zone percentage0.77 (0.65–0.86)−1.30
Multiple gray level size zone matrix features
57Multiple gray level small area emphasis0.78 (0.66–0.86)−0.98
59Multiple gray level intensity variability0.95 (0.92–0.97)2.26*
63Multiple gray level high intensity emphasis0.79 (0.68–0.87)−3.43*
65Multiple gray level high intensity small area emphasis0.85 (0.76–0.91)−3.44*

Comparisons are made between glioblastoma (GBM) and primary central nervous system lymphoma (PCNSL). A positive t-value means that the texture shows a higher value in GBM than in PCNSL, and a negative t-value means that the texture shows a lower value in GBM than in PCNSL.

indicates that the texture feature satisfies the false discovery rate constraint. ICC, intraclass correlation coefficient; CI, confidence interval.

Hierarchical clustering

On the heat map presentation of hierarchical clustering (Fig. 4), the cases (columns) could be divided into two main clusters. The vertical dendrogram showed that the lower half cluster was comprised of 27 GBMs and 2 PCNSLs. This cluster suggested relatively high values of features 2 (entropy), 4 (mean deviation), 5 (skewness), 9 (max), 13 (standard deviation), 26 (homogeneity), 27 (homogeneity 2), 41 (run length non-uniformity), 48 (small area emphasis), and 59 (multiple gray level intensity variability), localized in the left cluster of the horizontal dendrogram (features). On the other hand, the upper half cluster included 17 GBMs and 14 PCNSLs, which may be subdivided into two clusters characterized by the middle or the right cluster of the horizontal dendrogram. Approximately, one-third of the local cluster corresponded to PCNSL where features 22 (difference entropy), 25 (entropy), 42 (run percentage), 43 (short run emphasis), 46 (small area emphasis), 50 (zone percentage), and 57 (multiple gray level small area emphasis) were relatively high. The most upper-right cluster had 4 GBMs and 9 PCNSLs, exhibiting relatively high values in features 16 (autocorrelation), 32 (sum average), 34 (sum variance), 63 (multiple gray level high intensity emphasis), and 65 (multiple gray level high intensity small area emphasis). Among them, however, features 9 (max), 22 (difference entropy), 46 (small area emphasis), 50 (zone percentage), and 57 (multiple gray level small area emphasis) did not satisfy the FDR constraint (Table 2).
Fig. 4.

Hierarchical clustering between the texture features and the cases. The heatmap presentation with dendrograms shows how a texture feature expresses itself among the cases. Red indicates that the texture feature demonstrates a large positive z-score and green indicates that the texture feature demonstrates a large negative z-score. Each row of the heat map represents a specific texture feature across patients, and each column represents all features for a tumor. GBM, glioblastoma; LYM, primary central nervous system lymphoma.

Principal component analysis (PCA)

Principal component analysis showed that four principal components reasonably (cumulative percentage contribution > 80%) explained the variance of the feature set: features 42 (run percentage), 8 (median), 2 (entropy), and 41 (run length non-uniformity), in descending order of the percentage contribution. Features 42 (run percentage) and 8 (median) were significantly lower in GBM than in PCNSL, whereas features 2 (entropy) and 41 (run length non-uniformity) were significantly higher in GBM than in PCNSL (Table 2).

Discussion

The differentiation between GBM and PCNSL is important because the appropriate treatments are substantially different. However, differential diagnosis based on interpretation of conventional MR images may be sometimes challenging because atypical, solid enhancing GBM without visible necrosis may mimic PCNSL, and atypical PCNSL with visible necrosis may mimic GBM. Previous studies reported the usefulness of advanced MR imaging, including quantitative diffusion-, perfusion-, and susceptibility-weighted imaging or multiparametric combination of them, for the differentiation between GBM and PCNSL.[5,19-21] To the best of our knowledge, this is the first study focusing on the difference between post-contrast T1-weighted images of GBM and PCNSL using a radiomics approach. As is shown in Fig. 4, the expression patterns of post-contrast MR image-based texture features may vary considerably, not only between the entities (GBM and PCNSL), but also within the single entity (GBM or PCNSL). Some features can be shared between GBM and PCNSL. However, other features can be preferentially striking in GBM compared with PCNSL, and vice versa. For instance, from our results, PCNSL may exhibit high values in feature 32 (sum average) and feature 63 (multiple gray level high intensity emphasis). The rise of these values may be consistent with typical strong contrast enhancement (high voxel intensity) of PCNSL. Features 4 (mean deviation) and 13 (standard deviation) demonstrated positive z-scores in nearly half of GBMs, whereas most PCNSLs demonstrated negative z-scores. This may be explained by greater image heterogeneity (larger deviation of voxel intensity) of GBM compared with PCNSL. Interestingly, features 26 (homogeneity) and 27 (homogeneity 2), enhancing local gray level homogeneity, showed higher values in some GBMs than in PCNSLs. PCA suggested features 2 (entropy), 8 (median), 41 (run length non-uniformity), and 42 (run percentage) as the predominant (characteristic) features of our data set. The former two are first-order (histogram) features and the latter two are GLRLM features. Entropy quantifies the homogeneity of the image, indicating homogeneous regions with lower entropy values.[10] GLRLM features indicate the coarseness of a texture in a predetermined direction.[8] Run length non-uniformity indicates the similarity of the length of runs throughout the image, which shows low if the run lengths are alike. Run percentage indicates the homogeneity and the distribution of runs of an image in a given direction. For example, the run percentage is very high if the all gray levels have runs with a length of one.[15] Features 2 (entropy) and 41 (run length non-uniformity) showed higher values in GBM than in PCNSL (Table 2). This suggests that GBM may show lower homogeneity and lower similarity of the images than PCNSL. On the other hand, features 8 (median) and 42 (run percentage) showed lower values in GBM than in PCNSL. Necrosis in GBM may reasonably explain the lower median value of the images. Our run percentage results may represent lower image homogeneity in GBM compared with PCNSL. Radiomics refers to the extraction and analysis of large amounts of advanced quantitative imaging features with high throughput from medical images.[22] The potential of radiomics to contribute for decision support in oncology is growing. Quantitative image features based on intensity, shape, size or volume, and texture offer information on tumor phenotype and microenvironment that are distinct from that provided by standard clinical reports and laboratory test results.[23] A recent study on GBM reported that GLCM-derived homogeneity, angular second moment, inverse difference moment, and entropy from the contrast-enhancing lesion were significantly correlated with overall survival of GBM patients.[10] All of these four features assess the image homogeneity calculated with the formulas that are somewhat alike but somewhat different from one another. The present study worked on the difference of image texture features between GBM and PCNSL, using post-contrast MR image intensity and texture, but not with shape, size, or volume. Image shape and volume analysis requires accurate and precise delineation of lesion boundaries for segmentation. Manually-traced segmentations by experts are often used as a gold standard or ground truth, but manual segmentation is known as labor-intensive and error-prone.[22] In this study, we cropped a rectangular ROI on the largest contrast-enhancing lesion in each case because we needed to calculate dozens of 2D matrix-based texture features that require a rectangular voxel intensity set of the image, and thus we consider placement of a rectangular ROI is practical. It is also less laborious than manually tracing the lesion boundary by multiple clicks on a computer monitor. In addition, only reproducible measures were taken into the following analyses after the calculation of the ICC. The current WHO 2016 classification of CNS tumors has adopted a combined molecular-histological classification; thus, pathological diagnosis based on genetic alterations of a tumor is expected to become increasingly available in clinical practice. It is now widely accepted that the prognosis of GBM depends on genetically classified subtypes (24). As this retrospective study included GBM cases diagnosed before the WHO 2016 classification was published, the pathological diagnosis was based on conventional histology. Future works are encouraged on how genetic subtypes of GBM correlate with image texture features. Our study has some limitations. First, this was a retrospective study with a small number of patients at a single institution, which may have led to bias in patient selection. However, we enrolled consecutive patients who had been studied with the same MR imaging protocols on an identical MR system; therefore, data instability or bias derived from MR scanners and protocols would be minimized. Second, some texture features did not follow the normal distribution, and were thus excluded from the calculation of the ICC and PCA. ICC and PCA may have been used without mentioning the normality of measurements in the literature, although they assume the normal distribution of samples.[18] Third, in the present study, we did not make a comparison between results with texture analysis and those with the human visual assessment. It remains unclear whether texture analysis can outperform the visual assessment by radiologists. Finally, our study needed to exclude non-enhancing GBM, a rare imaging variant. Texture analysis on T2-weighted or fluid attenuated inversion recovery (FLAIR) images may be better when including non-enhancing GBM.

Conclusion

MR image-based texture analysis may be a promising tool for differential diagnosis between GBM and PCNSL, although expression patterns of texture features are partly shared between GBM and PCNSL. Among the texture features, first-order entropy, median, GLRLM run length non-uniformity, and run percentage may be characteristic and most efficiently indicate differences between GBM and PCNSL.

Ethics Statement

This retrospective study was approved by the institutional review board and informed consent was waived.
  22 in total

Review 1.  Primary CNS lymphoma.

Authors:  Fred H Hochberg; Joachim M Baehring; Ephraim P Hochberg
Journal:  Nat Clin Pract Neurol       Date:  2007-01

2.  Reliability, repeatability and reproducibility: analysis of measurement errors in continuous variables.

Authors:  J W Bartlett; C Frost
Journal:  Ultrasound Obstet Gynecol       Date:  2008-04       Impact factor: 7.299

3.  Atypical imaging features of Epstein-Barr virus-positive primary central nervous system lymphomas in patients without AIDS.

Authors:  H Y Lee; H S Kim; J W Park; H J Baek; S J Kim; C-G Choi
Journal:  AJNR Am J Neuroradiol       Date:  2013-02-14       Impact factor: 3.825

Review 4.  Primary central nervous system lymphoma: radiologic-pathologic correlation.

Authors:  K K Koeller; J G Smirniotopoulos; R V Jones
Journal:  Radiographics       Date:  1997 Nov-Dec       Impact factor: 5.333

5.  Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging.

Authors:  Philipp Kickingereder; Benedikt Wiestler; Felix Sahm; Sabine Heiland; Matthias Roethke; Heinz-Peter Schlemmer; Wolfgang Wick; Martin Bendszus; Alexander Radbruch
Journal:  Radiology       Date:  2014-05-03       Impact factor: 11.105

6.  Differentiation of primary central nervous system lymphomas and glioblastomas: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging without and with contrast-leakage correction.

Authors:  C H Toh; K-C Wei; C-N Chang; S-H Ng; H-F Wong
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-24       Impact factor: 3.825

7.  Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

Authors:  Marc Sanson; Yannick Marie; Sophie Paris; Ahmed Idbaih; Julien Laffaire; François Ducray; Soufiane El Hallani; Blandine Boisselier; Karima Mokhtari; Khe Hoang-Xuan; Jean-Yves Delattre
Journal:  J Clin Oncol       Date:  2009-07-27       Impact factor: 44.544

8.  Metrics and textural features of MRI diffusion to improve classification of pediatric posterior fossa tumors.

Authors:  D Rodriguez Gutierrez; A Awwad; L Meijer; M Manita; T Jaspan; R A Dineen; R G Grundy; D P Auer
Journal:  AJNR Am J Neuroradiol       Date:  2013-12-05       Impact factor: 3.825

9.  Robust Radiomics feature quantification using semiautomatic volumetric segmentation.

Authors:  Chintan Parmar; Emmanuel Rios Velazquez; Ralph Leijenaar; Mohammed Jermoumi; Sara Carvalho; Raymond H Mak; Sushmita Mitra; B Uma Shankar; Ron Kikinis; Benjamin Haibe-Kains; Philippe Lambin; Hugo J W L Aerts
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

10.  Radiomics: Images Are More than Pictures, They Are Data.

Authors:  Robert J Gillies; Paul E Kinahan; Hedvig Hricak
Journal:  Radiology       Date:  2015-11-18       Impact factor: 11.105

View more
  19 in total

1.  Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI.

Authors:  Yikyung Kim; Hwan-Ho Cho; Sung Tae Kim; Hyunjin Park; Dohyun Nam; Doo-Sik Kong
Journal:  Neuroradiology       Date:  2018-09-19       Impact factor: 2.804

Review 2.  Primary CNS lymphoma in Immunocompetent patients: Appearances on Conventional and Advanced Imaging with Review of literature.

Authors:  Anagha Joshi; Sneha Deshpande; Madhura Bayaskar
Journal:  J Radiol Case Rep       Date:  2022-07-31

3.  Texture analysis of T2-weighted MRI predicts SDH mutation in paraganglioma.

Authors:  Shotaro Naganawa; John Kim; Stephen S F Yip; Yoshiaki Ota; Ashok Srinivasan; Toshio Moritani
Journal:  Neuroradiology       Date:  2020-11-19       Impact factor: 2.804

4.  Marginal radiomics features as imaging biomarkers for pathological invasion in lung adenocarcinoma.

Authors:  Hwan-Ho Cho; Geewon Lee; Ho Yun Lee; Hyunjin Park
Journal:  Eur Radiol       Date:  2020-01-21       Impact factor: 5.315

5.  Glioblastoma and primary central nervous system lymphoma: differentiation using MRI derived first-order texture analysis - a machine learning study.

Authors:  Sarv Priya; Caitlin Ward; Thomas Locke; Neetu Soni; Ravishankar Pillenahalli Maheshwarappa; Varun Monga; Amit Agarwal; Girish Bathla
Journal:  Neuroradiol J       Date:  2021-03-03

Review 6.  Imaging in neuro-oncology.

Authors:  Hari Nandu; Patrick Y Wen; Raymond Y Huang
Journal:  Ther Adv Neurol Disord       Date:  2018-02-28       Impact factor: 6.570

Review 7.  Artificial intelligence in cancer imaging: Clinical challenges and applications.

Authors:  Wenya Linda Bi; Ahmed Hosny; Matthew B Schabath; Maryellen L Giger; Nicolai J Birkbak; Alireza Mehrtash; Tavis Allison; Omar Arnaout; Christopher Abbosh; Ian F Dunn; Raymond H Mak; Rulla M Tamimi; Clare M Tempany; Charles Swanton; Udo Hoffmann; Lawrence H Schwartz; Robert J Gillies; Raymond Y Huang; Hugo J W L Aerts
Journal:  CA Cancer J Clin       Date:  2019-02-05       Impact factor: 508.702

8.  Radiomic Based Machine Learning Performance for a Three Class Problem in Neuro-Oncology: Time to Test the Waters?

Authors:  Sarv Priya; Yanan Liu; Caitlin Ward; Nam H Le; Neetu Soni; Ravishankar Pillenahalli Maheshwarappa; Varun Monga; Honghai Zhang; Milan Sonka; Girish Bathla
Journal:  Cancers (Basel)       Date:  2021-05-24       Impact factor: 6.639

9.  Machine Learning-based Texture Analysis of Contrast-enhanced MR Imaging to Differentiate between Glioblastoma and Primary Central Nervous System Lymphoma.

Authors:  Akira Kunimatsu; Natsuko Kunimatsu; Koichiro Yasaka; Hiroyuki Akai; Kouhei Kamiya; Takeyuki Watadani; Harushi Mori; Osamu Abe
Journal:  Magn Reson Med Sci       Date:  2018-05-16       Impact factor: 2.471

10.  18F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma.

Authors:  Ziren Kong; Chendan Jiang; Ruizhe Zhu; Shi Feng; Yaning Wang; Jiatong Li; Wenlin Chen; Penghao Liu; Dachun Zhao; Wenbin Ma; Yu Wang; Xin Cheng
Journal:  Neuroimage Clin       Date:  2019-06-27       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.